# EpiVax

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/epivax

- Industry: Pharmaceuticals
- Headquarters: Providence, US
- Website: www.epivax.com/
- Latest round: Seed (Jun 1, 1998)
- Investors on record: 1

## About

EpiVax, Inc is a U.S.-based biotechnology and bioanalytical contract research organization (CRO) specializing in immunogenicity risk assessment for biologic drugs and vaccines. Founded in 1998, the company supports pharmaceutical and biotechnology developers by identifying and mitigating immune-related risks early in drug development through proprietary immunoinformatics software platforms and in vitro laboratory services.

## Funding rounds

- Seed, Jun 1, 1998 — Slater Technology Fund

## Investors

- Slater Technology Fund (https://capitalatlas.ai/funds/slater-technology-fund) — Seed